Table 3.
Adverse events
| Control group | Anisodamine group | |
|---|---|---|
| Perioperative period | ||
| Pulmonary infection | 1/29 (3.4) | 0/59 (0.0) |
| Staple-line leak | 0/29 (0.0) | 2/59 (3.4) |
| Postoperative 3 months | ||
| Alopecia | 10/26 (38.5) | 25/55 (45.5) |
| Anemia | 1/26 (3.9) | 2/55 (3.6) |
| Staple-line leak | 0/26 (0.0) | 1/55 (1.8)a |
| Chylous leakage | 1/26 (3.9) | 0/55 (0.0) |
| Gastroesophageal reflux | 2/26 (7.7) | 2/55 (3.6) |
Data are given as frequency/number (%)
aThis patient has suffered from staple-line leak for almost 2 months